Antilfa (odulimomab) / Sanofi - LARVOL DELTA

c-Met: A New Signature of Pro-inflammatory CD4+ T Cells in Multiple Sclerosis (AAN 2025) - "These results emphasize c-Met as an immune marker of highly pro-inflammatory and pro-migratory CD4+ T lymphocytes in MS."

CNS Disorders • Multiple Sclerosis • CD4 • IFNG • IL17A • ITGA4 • ITGB1 • MET • NTRK3